RB Lipton

6.3k total citations · 3 hit papers
41 papers, 4.7k citations indexed

About

RB Lipton is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, RB Lipton has authored 41 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Psychiatry and Mental health, 19 papers in Pathology and Forensic Medicine and 10 papers in Physiology. Recurrent topics in RB Lipton's work include Migraine and Headache Studies (38 papers), Trigeminal Neuralgia and Treatments (16 papers) and Sympathectomy and Hyperhidrosis Treatments (9 papers). RB Lipton is often cited by papers focused on Migraine and Headache Studies (38 papers), Trigeminal Neuralgia and Treatments (16 papers) and Sympathectomy and Hyperhidrosis Treatments (9 papers). RB Lipton collaborates with scholars based in United States, United Kingdom and Germany. RB Lipton's co-authors include CC Turkel, SD Silberstein, HC Diener, DW Dodick, SK Aurora, WF Stewart, RE DeGryse, ME Bigal, DC Buse and Xiaojun Hu and has published in prestigious journals such as Neurology, Headache The Journal of Head and Face Pain and Cephalalgia.

In The Last Decade

RB Lipton

39 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

2010 744 citations SK Aurora, DW Dodick et al. Cephalalgia profile →
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

2010 676 citations HC Diener, DW Dodick et al. Cephalalgia profile →
Global prevalence of chronic migraine: A systematic review

2009 502 citations AN Manack, CC Turkel et al. Cephalalgia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
RB Lipton United States	29	4.3k	2.7k	1.8k	771	481	41	4.7k
Roberto De Simone Italy	23	3.4k 0.8×	2.1k 0.8×	1.3k 0.7×	886 1.1×	482 1.0×	73	4.4k
Manjit Matharu United Kingdom	39	5.0k 1.2×	3.8k 1.4×	2.3k 1.3×	1.0k 1.3×	450 0.9×	224	6.2k
Enrico Marano Italy	14	3.1k 0.7×	1.9k 0.7×	1.2k 0.7×	662 0.9×	458 1.0×	34	3.8k
Andrew Blumenfeld United States	35	3.3k 0.8×	2.3k 0.8×	1.4k 0.8×	958 1.2×	476 1.0×	126	4.0k
Paul Winner United States	35	4.2k 1.0×	2.3k 0.8×	1.9k 1.0×	426 0.6×	1.1k 2.2×	111	4.8k
RB Lipton United States	12	3.3k 0.8×	2.0k 0.7×	1.1k 0.6×	331 0.4×	368 0.8×	12	3.6k
Patricia Pozo‐Rosich Spain	37	4.1k 1.0×	2.3k 0.8×	1.3k 0.7×	1.3k 1.6×	380 0.8×	206	5.2k
Sepideh F. Varon United States	27	3.1k 0.7×	2.0k 0.7×	885 0.5×	510 0.7×	320 0.7×	38	3.6k
Kristina M. Fanning United States	39	4.1k 1.0×	2.0k 0.7×	1.1k 0.6×	276 0.4×	441 0.9×	88	4.8k
Gian Camillo Manzoni Italy	30	2.9k 0.7×	1.9k 0.7×	1.3k 0.7×	379 0.5×	205 0.4×	121	3.4k

Countries citing papers authored by RB Lipton

Since Specialization

Citations

This map shows the geographic impact of RB Lipton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RB Lipton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RB Lipton more than expected).

Fields of papers citing papers by RB Lipton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RB Lipton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RB Lipton. The network helps show where RB Lipton may publish in the future.

Co-authorship network of co-authors of RB Lipton

This figure shows the co-authorship network connecting the top 25 collaborators of RB Lipton. A scholar is included among the top collaborators of RB Lipton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RB Lipton. RB Lipton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lipton, RB, Ravi Iyer, Joshua M. Cohen, et al.. (2019). PND102 BURDEN OF COMORBID DEPRESSION AND ANXIETY ON MIGRAINE-SPECIFIC HEALTH-RELATED QUALITY OF LIFE IN ADULT MIGRAINE PATIENTS IN THE UNITED STATES. Value in Health. 22. S756–S756. 1 indexed citations

Lipton, RB, et al.. (2018). Estimating Patient Utility in Migraine: Longitudinal Analysis of Erenumab Clinical Trial Data. Value in Health. 21. S225–S225. 1 indexed citations

Lipton, RB, Alan Brennan, Stephen Palmer, et al.. (2017). Novel Biologics Versus Conventional Preventive Therapies In Migraine: A Framework for Economic Evaluation. Value in Health. 20(9). A732–A732. 1 indexed citations

Lipton, RB, et al.. (2014). EHMTI-0169. Trajectories of headache days over one year (5 waves) in chronic and episodic migraineurs participating in the chronic migraine epidemiology and outcomes (cameo) study. The Journal of Headache and Pain. 15(S1). 1 indexed citations

Manack, AN, et al.. (2013). Major life events, stress appraisal, and migraine: results of the American Migraine Prevalence and Prevention (AMPP) study. The Journal of Headache and Pain. 14(S1). 3 indexed citations

Ashina, Sait, et al.. (2013). Association of lower level of leisure-related physical activity with primary headaches. The Journal of Headache and Pain. 14(S1). 3 indexed citations

Diener, HC, DW Dodick, SK Aurora, et al.. (2011). placebo-controlled phase of the PREEMPT 2 trial OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized,. 64 indexed citations

Katsarava, Zaza, AN Manack, M-S Yoon, et al.. (2011). Chronic migraine: Classification and comparisons. Cephalalgia. 31(5). 520–529. 59 indexed citations

Scher, I, RB Lipton, WF Stewart, & Marcelo E. Bigal. (2009). Patterns of medication use by chronic and episodic headache sufferers in the general population: Results from the frequent headache epidemiology study. Cephalalgia. 30(3). 321–328. 85 indexed citations

10.

Bigal, ME, et al.. (2009). Weight Change and Clinical Markers of Cardiovascular Disease Risk During Preventive Treatment of Migraine. Cephalalgia. 29(11). 1188–1196. 9 indexed citations

11.

Scher, I, WF Stewart, Dawn C. Buse, David S. Krantz, & RB Lipton. (2008). Major Life Changes Before and After the Onset of Chronic Daily Headache: A Population-Based Study. Cephalalgia. 28(8). 868–876. 51 indexed citations

12.

Diener, HC, et al.. (2007). Identification of Negative Predictors of Pain-Free Response to Triptans: Analysis of the Eletriptan Database. Cephalalgia. 28(1). 35–40. 39 indexed citations

13.

Bigal, ME, SJ Tepper, FD Sheftell, AM Rapoport, & RB Lipton. (2006). Field Testing Alternative Criteria for Chronic Migraine. Cephalalgia. 26(4). 477–482. 48 indexed citations

14.

Bigal, ME, et al.. (2005). Patterns of Medical Diagnosis and Treatment of Migraine and Probable Migraine in a Health Plan. Cephalalgia. 26(1). 43–49. 37 indexed citations

15.

Bigal, ME, SJ Tepper, Michele Feleppa, et al.. (2005). Headache Prevention Outcome and Body Mass Index. Cephalalgia. 26(4). 445–450. 39 indexed citations

16.

Lipton, RB, et al.. (2003). Migraine Headache Disability and Health-Related Quality-of-life: A Population-Based Case-Control Study from England. Cephalalgia. 23(6). 441–450. 222 indexed citations

17.

Stewart, WF, RB Lipton, David Simon, Michael Von Korff, & Joshua N. Liberman. (1998). Reliability of an Illness Severity Measure for Headache in A Population Sample of Migraine Sufferers. Cephalalgia. 18(1). 44–51. 89 indexed citations

18.

Stewart, WF, RB Lipton, & David Simon. (1996). Work-Related Disability: Results From the American Migraine Study. Cephalalgia. 16(4). 231–238. 221 indexed citations

19.

Olesen, Jes & RB Lipton. (1994). Migraine classification and diagnosis. International Headache Society criteria.. PubMed. 44(6 Suppl 4). S6–10. 46 indexed citations

20.

Lipton, RB, Geoffrey R. Weiss, Carol Harris, et al.. (1991). Headache in HIV‐1‐Related Disorders. Headache The Journal of Head and Face Pain. 31(8). 518–522. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact